Quantum Biopharma (QNTM)
NASDAQ:QNTM
Want to see QNTM full AI Analyst Report?
Quantum Biopharma (QNTM) Ownership Overview
15.74% Insiders
2.57% Other Institutional Investors
3.06% ETFs
78.64% Public Companies and
Individual Investors
The ownership structure of Quantum Biopharma (QNTM) stock is a mix of institutional, retail, and individual investors. , 15.74% is owned by Insiders, and 78.64% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 09, 2026 | xxxxxxxxxxxxx | C$55554 | |
Apr 08, 2026 | xxxxxxxxxxxxx | C$110001 | |
Apr 08, 2026 | xxxxxxxxxxxxx | C$653183 | |
Nov 27, 2025 | xxxxxxxxxxxxx | $243886 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 623,633 | Insider | 10.70% | 3,242,892 | |
| 239,998 | Insider | 4.12% | 1,247,990 | |
| 178,090 | Institution | 3.06% | 926,068 | |
| 51,417 | Insider | 0.88% | 267,368 | |
| 2,500 | Insider | 0.04% | 13,000 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Quantum Biopharma (QNTM)?
According to the latest TipRanks data, approximately 2.57% of the company's stock is held by institutional investors, 15.74% is held by insiders, and 78.64% is held by retail investors.
What percentage of Quantum Biopharma (QNTM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.57% of Quantum Biopharma (QNTM) stock is held by institutional investors.
What percentage of Quantum Biopharma (QNTM) stock is held by retail investors?
According to the latest TipRanks data, approximately 78.64% of Quantum Biopharma (QNTM) stock is held by retail investors.
Who owns the most shares of Quantum Biopharma (QNTM)?
Anthony John Durkacz owns the most shares of Quantum Biopharma (QNTM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.